OTSUKA PHARMACEUTICALS (U.K.) LTD.
Get an alert when OTSUKA PHARMACEUTICALS (U.K.) LTD. files next
Leroy will email you the moment a new filing lands at Companies House — one short note per filing, nothing else.
Next accounts due
2026-09-30 (in 4mo)
Last filed for 2024-12-31
Confirmation statement due
2026-08-28 (in 3mo)
Last made up 2025-08-14
Watchouts
None on the register
Cash
£62K
-0.6% vs 2023
Net assets
£3M
+4.4% vs 2023
Employees
47
+4.4% vs 2023
Profit before tax
£978K
+16.4% vs 2023
Name history
Renamed 2 times since incorporation
- OTSUKA PHARMACEUTICALS (U.K.) LTD. 2002-03-27 → present
- OTSUKA PHARMA LTD. 1998-11-03 → 2002-03-27
- INTERCEDE 1348 LIMITED 1998-08-14 → 1998-11-03
Net assets
2-year trend · vs Consumer Discretionary median
Accounts
2-year trend · latest reflected 2024-12-31
| Metric | Trend | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Turnover | £27,739,543 | £30,995,269 | |
| Operating profit | £734,539 | £915,437 | |
| Profit before tax | £840,189 | £977,924 | |
| Net profit | £596,635 | £727,633 | |
| Cash | £62,321 | £61,956 | |
| Total assets less current liabilities | £3,009,953 | £3,140,952 | |
| Net assets | £3,009,954 | £3,140,952 | |
| Equity | £3,009,954 | £3,140,952 | |
| Average employees | 45 | 47 | |
| Wages | £4,649,268 | £4,646,752 |
Values shown as filed in the company's annual accounts. — indicates the figure wasn't present under that line item in that period. About these numbers
Ratios
Computed from the line items above — sparklines read oldest → newest
| Ratio | Trend | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Operating margin | 2.6% | 3.0% | |
| Net margin | 2.2% | 2.3% | |
| Return on capital employed | 24.4% | 29.1% | |
| Gearing (liabilities / total assets) | 69.6% | 72.8% | |
| Current ratio | 1.32x | 1.30x | |
| Interest cover | — | 998.30x |
Margins divide P&L lines by turnover. Gearing is liabilities over total assets. Current ratio is current assets over creditors falling due within one year. Interest cover is operating profit over absolute finance costs. Sector-distribution context coming next.
Audit & accounting basis
- Accounting basis
- FRS 101
- Reporting scope
- Standalone (parent only)
- Auditor
- KPMG LLP
- Audit opinion
- Unqualified (clean)
- Going concern
- Affirmed
“The directors have prepared the financial statements on a going concern basis having prepared cash flow forecasts for a period of 12 months from the date of approval of these financial statements. As detailed in the Strategic Report, the core business of the company is performing as expected and has demonstrated resilience in the face of significant demands.”
Significant events
- “There were no post balance sheet events between 31 December 2024 and the signing date for the approval of financial statements.”
Auditor, going-concern and subsidiary information is drawn from the narrative of the latest annual accounts. About these numbers
People
2 active · 13 resigned
| Name | Role | Appointed | Born | Nationality |
|---|---|---|---|---|
| GYNNE, Ryan | Director | 2020-02-03 | Apr 1977 | British |
| O'CONNOR, Annabel Barbara | Director | 2020-10-17 | Oct 1982 | British |
Show 13 resigned officers
| Name | Role | Appointed | Resigned |
|---|---|---|---|
| MITRE SECRETARIES LIMITED | Corporate Nominee Secretary | 1998-08-14 | 2024-04-30 |
| BEVAN, David Gower | Director | 2014-08-01 | 2016-04-18 |
| DHILLON, Charanjit Cheryl | Director | 2009-01-22 | 2014-08-01 |
| DHILLON, Cheryl Charanjit | Director | 2016-04-18 | 2020-10-31 |
| GEDDES, Grant | Director | 1998-10-23 | 2014-08-01 |
| HORI, Tetsusaburo | Director | 2005-07-01 | 2009-01-22 |
| JUELICHER, Klaus | Director | 1998-10-23 | 2002-06-28 |
| PAGE, Andrew Edward | Director | 2014-08-01 | 2017-07-17 |
| PEARCE, Stewart Benjamin | Director | 2017-07-17 | 2020-10-17 |
| REEVES, Barbara | Nominee Director | 1998-08-14 | 1998-10-23 |
| RICH, Michael William | Nominee Director | 1998-08-14 | 1998-10-23 |
| TOBA, Tadasu | Director | 2002-06-28 | 2005-06-30 |
| YOSHIKAWA, Hiromi | Director | 1998-10-23 | 2002-06-28 |
Ownership
Persons with significant control
| Name | Kind | Nature of control | Notified | Status |
|---|---|---|---|---|
| Otsuka Pharmaceutical Europe Ltd. | Corporate entity | Shares 75–100%, Voting 75–100%, Appoints directors, Significant influence | 2016-04-06 | Active |
Filing timeline
Last 20 of 139 total filings
Material constitutional events — rename, articles re-file, resolution
- 2020-11-09 RESOLUTIONS Resolution
- 2020-11-09 MA Memorandum articles
| Date | Type | Category | Description | |
|---|---|---|---|---|
| 2025-08-26 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2025-08-05 | AA | accounts | Accounts with accounts type full | |
| 2024-08-27 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2024-08-22 | AA | accounts | Accounts with accounts type full | |
| 2024-05-24 | TM02 | officers | Termination secretary company with name termination date | |
| 2023-09-28 | AA | accounts | Accounts with accounts type full | |
| 2023-08-24 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2023-06-02 | AD01 | address | Change registered office address company with date old address new address | |
| 2022-10-07 | AA | accounts | Accounts with accounts type full | |
| 2022-08-23 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2021-09-22 | AA | accounts | Accounts with accounts type full | |
| 2021-08-16 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2021-02-04 | AP01 | officers | Appoint person director company with name date | |
| 2021-02-04 | TM01 | officers | Termination director company with name termination date | |
| 2021-02-04 | TM01 | officers | Termination director company with name termination date | |
| 2020-11-09 | RESOLUTIONS | resolution | Resolution | |
| 2020-11-09 | MA | incorporation | Memorandum articles | |
| 2020-10-28 | AA | accounts | Accounts with accounts type full | |
| 2020-08-14 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2020-05-15 | AP01 | officers | Appoint person director company with name date |
Public-record activity
Raw counts from Companies House — last 12–24 months
- Filings
- 2
- Capital events
- 0
- Officers appointed
- 0
- Officers resigned
- 0
last 12 months
last 24 months
last 12 months
last 12 months
Direct counts from the register. No score, no rating — see the Filing timeline for the underlying events.
Year-on-year
FY2023 → FY2024 · period ending 2024-12-31 vs 2023-12-31
-
Turnover
+11.7%
£27,739,543 £30,995,269
-
Cash
-0.6%
£62,321 £61,956
-
Net assets
+4.4%
£3,009,954 £3,140,952
-
Employees
+4.4%
45 47
-
Operating profit
+24.6%
£734,539 £915,437
-
Profit before tax
+16.4%
£840,189 £977,924
-
Wages
-0.1%
£4,649,268 £4,646,752
Each % is (latest − prior) ÷ |prior| for the line item as filed. The comparison is only shown when the latest and prior accounts cover broadly equal-length periods — short or long stubs (typical around incorporation or a year-end change) are suppressed rather than misrepresented. Lines a company doesn't report are omitted. About these numbers